GMEX Robotics Corp (GMEX) Stock Analysis

$1.030

-0.048 (-4.63%)At close

Loading chart…

High: 1.100
Open: 1.100
VWAP: 1.04
Vol: 377.85K
Mkt Cap: —
Low: 1.000
Amount: 394.22K
EV/EBITDA, TTM: 0.00

GMEX Robotics Corporation, formerly Fitell Corporation, is a technology company. The Company is focused on designing, manufacturing, and commercializing AI-driven robotic solutions for the consumer market, building on its foundation of expertise in fitness and health products. The Company is operating at the intersection of consumer health and advanced automation.

www.fitellcorp.com

AI analysis of GMEX Robotics Corp (GMEX)

sell

GMEX is not a good buy right now. The current price is $1.03, and the stock has seen a staggering year-to-date change of -99.14%. Additionally, the RSI is at 28.175, indicating that the stock is in oversold territory, but this is not a strong enough signal to justify a buy given the overall negative performance and financial metrics.

Valuation Metrics

The current forward P/E ratio for GMEX Robotics Corp (GMEX) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E

Current P/E

0.00

Forward EV/EBITDA

5Y Average EV/EBITDA

Current EV/EBITDA

0.00

Forward P/S

5Y Average P/S

Current P/S

0.00

Events Timeline

2026-07-28 (ET)

09:30:00

GMEX Robotics Enters Share Purchase Agreement with Alpha Meta AI

2026-07-14 (ET)

09:30:00

GMEX Robotics Signs Letter of Intent for Acquisition

2026-07-06 (ET)

09:00:00

GMEX Robotics Signs LOI to Acquire Equity Interest in California Company

2026-07-01 (ET)

20:00:00

GMEX Robotics Corp Trading Halted, News Pending

2026-06-29 (ET)

19:00:00

Stock Futures Slightly Lower as Investors Await Middle East News

Show More Events

News

GMEX FAQ — answered by Alphio AI

GMEX Robotics Corporation, formerly Fitell Corporation, is a technology company. The Company is focused on designing, manufacturing, and commercializing AI-driven robotic solutions for the consumer market, building on its foundation of expertise in fitness and health products. The Company is operating at the intersection of consumer health and advanced automation. It operates in the Consumer Cyclicals sector.

GMEX is not a good buy right now. The current price is $1.03, and the stock has seen a staggering year-to-date change of -99.14%. Additionally, the RSI is at 28.175, indicating that the stock is in oversold territory, but this is not a strong enough signal to justify a buy given the overall negative performance and financial metrics.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.